XXXX and @entity748 : how common in pediatrics?

@entity1 @entity748 @entity565 @entity8193 @entity520 @entity1576
BACKGROUND: @entity8193 is a well described phenomenon in adult @entity1 with severe @entity565 . However, this entity is rarely reported in @entity1 with @entity748 . OBJECTIVE: To report our experience in a 13-year-old @entity1 who developed @entity8193 as a complication of @entity748 and to investigate the prevalence of this complication of severe @entity565 . We sought to determine the frequency of @entity8193 in such @entity1 and to review etiologies of @entity8193 . METHODS: 1) Observations on the clinical and laboratory findings in an adolescent @entity1 with @entity748 who developed @entity8193 were recorded. 2) The medical records of 100 @entity1 and adolescents with @entity748 admitted to an intensive care unit were reviewed for laboratory evidence of @entity8193 . 3) We also reviewed our own previous experience of @entity748 with @entity1576 . RESULTS: Among 100 @entity1 admitted to a pediatric intensive care unit for @entity748 , a single case of isolated @entity520 was identified. This proved to be attributable to @entity8193 . When records of @entity1 with severe @entity1576 were examined, no cases of @entity520 were found. CONCLUSIONS: Although rare, @entity8193 does occur in pediatric-aged @entity1 during @entity748 . It is important that this complication be recognized and treated because @entity520 may inhibit the effectiveness of bronchodilator therapy, produce electrolyte disturbances, and cause serious adverse effects on the @entity1 's cardiovascular system.
